|
显示项目 464606-464615 / 2348973 (共234898页)
<< < 46456 46457 46458 46459 46460 46461 46462 46463 46464 46465 > >>
每页显示[10|25|50]项目
| 東海大學 |
2009-12-08 |
HEp-2 cell classification in indirect immunofluorescence images
|
Hsieh, T.-Y.a , Huang, Y.-C.b , Chung, C.-W.b, Huang, Y.-L.b |
| 東海大學 |
2012-03-19 |
HEp-2 cell images classification based on textural and statistic features using self-organizing map
|
Huang, Y.-C.a , Hsieh, T.-Y.b, Chang, C.-Y.a, Cheng, W.-T.a, Lin, Y.-C.a, Huang, Y.-L. |
| 東海大學 |
2012-03-19 |
HEp-2 cell images classification based on textural and statistic features using self-organizing map
|
Huang, Y.-C.a , Hsieh, T.-Y.b, Chang, C.-Y.a, Cheng, W.-T.a, Lin, Y.-C.a, Huang, Y.-L. |
| 國立成功大學 |
2002-07-29 |
Hepa-1 小鼠細胞蛋白質體如何受2 3 7 8-四氯戴奧辛影響
|
洪千雯; Hung, Chien-Wen |
| 國立臺灣大學 |
2015 |
Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity
|
Xu, Ding; Olson, Joshua; Cole, Jason N.; van Wijk, Xander M.; Brinkmann, Volker; Zychlinsky, Arturo; Nizet, Victor; Esko, Jeffrey D.; Chang, Yung-Chi; 張永祺 |
| 臺大學術典藏 |
2000 |
Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
|
Wei-Hsuan Yu;Woessner Jr. J.F.; WEI-HSUAN YU; Woessner Jr. J.F. |
| 國立成功大學 |
2009-05 |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 臺大學術典藏 |
2020-02-19T09:33:57Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:55Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
显示项目 464606-464615 / 2348973 (共234898页)
<< < 46456 46457 46458 46459 46460 46461 46462 46463 46464 46465 > >>
每页显示[10|25|50]项目
|
